APR 14, 202667 MINS READ
Quaternized chitosan is derived from chitosan, a β-1,4-linked copolymer of glucosamine (2-amino-2-deoxy-β-D-glucose) and N-acetylglucosamine units, which itself originates from the deacetylation of chitin—a natural polysaccharide abundantly available as a byproduct of the crustacean processing industry 6714. The quaternization reaction introduces three additional alkyl groups to the primary amine, forming a quaternary ammonium cation with a permanent positive charge that remains stable across physiological pH ranges 51113.
The degree of quaternization (DQ) is a critical structural parameter that governs the physicochemical and biological properties of quaternized chitosan. Typical DQ values range from 10% to 60%, depending on the synthesis conditions and intended application 817. For instance, quaternized cyanobenz[f]isoindole chitosan derivatives with DQ values around 10%–40% and degree of N-substitution (DS) of 5%–10% have been reported for fluorescent drug delivery applications 8. The molecular weight of the parent chitosan also plays a significant role: high molecular weight chitosan (0.5–3 million Da) with deacetylation degrees of 70%–90% is commonly employed to ensure adequate chain length for subsequent functionalization 17.
The quaternization process typically employs reagents such as glycidyl trimethylammonium chloride (GTMAC), methyl iodide, or ethyl bromide under alkaline conditions 41516. The reaction mechanism involves nucleophilic substitution at the amine nitrogen, yielding N,N,N-trimethyl chitosan chloride or analogous quaternary ammonium salts. The resulting quaternized chitosan exhibits enhanced water solubility (≥25 mg/mL) and maintains a positive charge density that facilitates electrostatic interactions with negatively charged biological surfaces, such as bacterial cell membranes and mucosal tissues 2617.
The most widely adopted synthesis route for quaternized chitosan involves the reaction of chitosan with quaternizing agents in the presence of an inorganic base. A representative procedure includes dissolving chitosan in an organic solvent such as N-methyl-2-pyrrolidone (NMP) or isopropanol, followed by the addition of sodium hydroxide and a quaternizing agent (e.g., methyl iodide or GTMAC) 415. The reaction is typically conducted under reflux at 60°C for 1–12 hours, with continuous stirring to ensure homogeneous quaternization 415.
For example, one synthesis protocol describes mixing 12 g of chitosan (molecular weight 70 kDa) with 240 mL of NMP, 70 mL of methyl iodide, 31.2 g of sodium iodide, and 66 mL of 15% sodium hydroxide solution, followed by reflux at 60°C for one hour 15. The product is then purified by dialysis against deionized water and lyophilized to obtain quaternized chitosan with controlled DQ values. The concentration of the quaternizing agent is a key parameter: GTMAC concentrations of 0.025–0.10 g/mL have been reported to yield DQ values in the range of 10%–60% 17.
Recent innovations have focused on one-pot synthesis methods that simplify the quaternization process and improve reproducibility. In one approach, chitosan, an inorganic base, a dispersant containing hydroxyl groups, and an etherifying agent are added simultaneously, followed by a gradual increase in temperature and pressure to drive the etherification reaction 18. This method avoids the tedious multi-step addition of reagents and reduces the risk of side reactions, such as polymer degradation or incomplete quaternization.
Another advanced strategy involves the preparation of Schiff base intermediates prior to quaternization. In this method, the primary amine groups of carboxymethyl chitosan are first reacted with aldehydes to form Schiff bases, which are subsequently reduced with sodium borohydride (NaBH₄) to yield N-substituted carboxymethyl chitosan 4. The N-substituted derivative is then quaternized with iodomethane under alkaline conditions (I⁻ concentration adjusted to 0.2 mol/L with sodium iodide) for 12 hours, resulting in quaternized carboxymethyl chitosan iodide with enhanced antifungal activity 4.
Key process parameters that influence the degree of quaternization and molecular weight of the final product include:
Quality control measures include nuclear magnetic resonance (NMR) spectroscopy to confirm the degree of quaternization, gel permeation chromatography (GPC) to assess molecular weight distribution, and Fourier-transform infrared (FTIR) spectroscopy to verify the presence of quaternary ammonium groups 51112. The solubility of the quaternized chitosan in water at neutral pH is also a critical quality indicator, with target solubility values of ≥25 mg/mL 17.
One of the most significant advantages of quaternized chitosan over native chitosan is its enhanced water solubility across a wide pH range. Native chitosan is soluble only in acidic solutions (pH < 6) due to protonation of the amine groups, which limits its applicability in neutral or alkaline environments 6714. In contrast, quaternized chitosan carries a permanent positive charge on the quaternary ammonium moiety, rendering it soluble in water at neutral and even alkaline pH values 51112. This pH-independent solubility is particularly advantageous for biomedical applications, such as drug delivery and wound dressings, where physiological pH conditions (pH 7.4) must be maintained 3617.
Quaternized chitosan exhibits potent antimicrobial activity against a broad spectrum of microorganisms, including Gram-positive and Gram-negative bacteria, fungi, and certain viruses 561112. The antimicrobial mechanism is primarily attributed to the electrostatic interaction between the positively charged quaternary ammonium groups and the negatively charged components of microbial cell membranes, such as lipopolysaccharides and phospholipids 51112. This interaction disrupts membrane integrity, leading to leakage of intracellular contents and cell death.
The antibacterial efficacy of quaternized chitosan is influenced by several structural factors, including the degree of quaternization, the length of the alkyl substituent, and the molecular weight of the polymer. Studies have shown that antibacterial activity increases with decreasing chain length of the alkyl substituent, as shorter chains facilitate closer contact with the bacterial cell surface 51112. For example, quaternized chitosan derivatives with trimethyl ammonium groups exhibit higher antibacterial activity than those with longer alkyl chains 51112.
The positive charge density on quaternized chitosan also enhances its mucoadhesive properties, enabling strong adhesion to negatively charged mucosal surfaces in the gastrointestinal tract, nasal cavity, and ocular tissues 19. This mucoadhesion prolongs the residence time of drug-loaded nanoparticles at the absorption site, thereby improving bioavailability and therapeutic efficacy 19. For instance, fucoidan-quaternized chitosan nanoparticles have been developed for vaccine delivery, leveraging the mucoadhesive properties of quaternized chitosan to enhance antigen uptake by immune cells 1.
Quaternized chitosan also facilitates cellular uptake via endocytosis. The positively charged polymer interacts with negatively charged cell membrane components, triggering receptor-mediated or adsorptive endocytosis 19. This property is exploited in gene delivery applications, where quaternized chitosan serves as a non-viral vector for transfecting cells with plasmid DNA or siRNA 1.
Quaternized chitosan can be formulated into hydrogels with tunable mechanical properties by incorporating photocrosslinkable groups, such as methacrylate or acrylate moieties, onto the polymer backbone 6714. Upon exposure to UV light in the presence of a photoinitiator, these groups undergo free radical polymerization to form a crosslinked hydrogel network 6714. The resulting hydrogels exhibit elastic moduli in the range of 1–10 kPa, depending on the degree of crosslinking and the concentration of the polymer 67.
The rheological properties of quaternized chitosan solutions are also of interest for processing applications. Viscosity measurements indicate that quaternized chitosan solutions exhibit shear-thinning behavior, with viscosity decreasing as shear rate increases 2. This pseudoplastic behavior facilitates processing operations such as spray coating, electrospinning, and 3D printing 210.
Quaternized chitosan nanoparticles have emerged as versatile carriers for the delivery of small-molecule drugs, peptides, proteins, and nucleic acids 1915. The nanoparticles are typically prepared by ionic gelation, wherein a quaternized chitosan solution is mixed with an anionic crosslinker (e.g., sodium tripolyphosphate) or an anionic biopolymer (e.g., fucoidan) to induce spontaneous self-assembly into nanoparticles 19.
For example, fucoidan-quaternized chitosan nanoparticles have been developed for vaccine delivery, with particle sizes in the range of 100–300 nm and zeta potentials of +20 to +40 mV 1. These nanoparticles encapsulate antigens and adjuvants, protecting them from enzymatic degradation and facilitating uptake by antigen-presenting cells 1. In another application, gambogic acid-loaded quaternized chitosan nanoparticles (particle size ~140 nm) have been prepared for cancer therapy, demonstrating enhanced cellular uptake and cytotoxicity against tumor cells compared to free gambogic acid 15.
The drug loading efficiency and release kinetics of quaternized chitosan nanoparticles can be modulated by adjusting the degree of quaternization, the molecular weight of the polymer, and the crosslinking density 1915. Sustained release profiles over 24–72 hours have been achieved, making these nanoparticles suitable for controlled drug delivery applications 19.
Quaternized chitosan hydrogels have been developed as antimicrobial coatings for medical devices, including contact lenses, urinary catheters, and wound dressings 6714. The hydrogels are formed by grafting photocrosslinkable groups (e.g., methacrylate or polyethylene glycol derivatives) onto the quaternized chitosan backbone, followed by UV-induced polymerization 6714. The resulting hydrogel matrix is hydrophilic, which intrinsically prevents the nonspecific attachment of microbes, while the quaternary ammonium groups provide broad-spectrum antimicrobial activity 6714.
For contact lens applications, quaternized chitosan hydrogels have been shown to inhibit the adhesion and biofilm formation of common ocular pathogens, such as Staphylococcus aureus and Pseudomonas aeruginosa, without compromising optical transparency or oxygen permeability 6714. The hydrogels maintain their antimicrobial efficacy even after prolonged exposure to physiological fluids, making them suitable for long-term use 67.
In wound care, quaternized chitosan hydrogels have been formulated with additional functional components, such as nano-silver particles, curcumin, and zwitterionic polymers, to create multifunctional dressings with antimicrobial, anti-inflammatory, and wound-healing properties 17. For instance, a nano-silver/dual-modified chitosan hydrogel dressing has been developed with a semi-interpenetrating polymer network structure, exhibiting a discoloration effect that allows visual monitoring of wound infection status 17. The dressing demonstrates sustained release of silver ions over 7 days, maintaining antimicrobial activity against both Gram-positive and Gram-negative bacteria 17.
Quaternized chitosan has been incorporated into hemostatic compositions for controlling topical bleeding in surgical and trauma settings 3. A representative formulation comprises a mixture of quaternized chitosan and phosphorylated chitosan in a weight ratio of 1:3 to 3:1, combined with polyphenolic compounds (e.g., tannic acid), peptides, and gelling agents 3. The quaternized chitosan component provides positive charge density, which promotes platelet aggregation and activation of the coagulation cascade, while the phosphorylated chitosan enhances the mechanical strength of the resulting clot 3.
The hemostatic efficacy of this composition has been demonstrated in animal models of hemorrhage, where application of the quaternized chitosan-based gel reduced bleeding time by 50%–70% compared to untreated controls 3. The composition is also biocompatible and biodegradable, with no adverse effects observed in histopathological examinations 3.
Quaternized chitosan has been integrated into anionic polyurethane soft foams to create antimicrobial scaffolds for tissue engineering and medical implant applications 2. The synthesis involves pre-mixing a quaternized chitosan acid solution with polyether polyol, amine catalyst, crosslinking agent, water, and anionic foam stabilizer (component A), followed by the addition of polyisocyanate (component B) to initiate foaming and curing 2. The isocyanate reacts with the quaternized chitosan, chemically anchoring it onto the growing polyurethane chain and achieving "in situ stabilization" 2.
The resulting quaternized chitosan/anionic polyurethane foam exhibits a porous structure with pore sizes in the range of 100–500 μm, suitable for cell infiltration and tissue ingrowth 2. The foam also demonstrates antimicrobial activity against Staphylococcus aureus and Escherichia coli, with bacterial reduction rates exceeding 99% after 24 hours of contact 2. These properties make the foam suitable for high-end home and medical material applications, such as mattress toppers, wheelchair cushions, and wound care products 2.
Quaternary ammonium functionalized chitosan resins have been developed for the removal of nitrate and other anionic contaminants from drinking water 16. The resin is prepared by converting chitosan flakes into gel beads, crosslinking with glutaraldehyde, and then quaternizing with ethyl bromide to introduce quaternary ammonium chloride functional groups 16. The resulting beads have a diameter of approximately 0.9 mm, which is comparable to commercial synthetic nitrate-removing resins 16.
The nitrate removal efficiency of the quaternized
| Org | Application Scenarios | Product/Project | Technical Outcomes |
|---|---|---|---|
| National Defense Medical Center | Vaccine delivery systems requiring enhanced immune response and targeted delivery to antigen-presenting cells for immunization applications. | Fucoidan-Quaternized Chitosan Nanoparticles | Enhanced cellular uptake and antigen delivery with particle sizes of 100-300 nm and zeta potentials of +20 to +40 mV, providing protection from enzymatic degradation and facilitating uptake by antigen-presenting cells. |
| Nanyang Technological University | Antimicrobial coatings for medical devices including contact lenses, urinary catheters, and wound dressings requiring long-term biocompatibility and infection prevention. | Quaternized Chitosan Hydrogel Contact Lens Coating | Broad-spectrum antimicrobial activity against Staphylococcus aureus and Pseudomonas aeruginosa while maintaining optical transparency and oxygen permeability, with hydrophilic matrix preventing nonspecific microbial attachment. |
| Zhejiang University | Advanced wound care applications requiring antimicrobial activity, visual infection status monitoring, and multifunctional properties including anti-inflammatory and wound-healing capabilities. | Nano-Silver/Dual-Modified Chitosan Hydrogel Dressing | Sustained silver ion release over 7 days with discoloration effect for visual wound infection monitoring, achieving >99% bacterial reduction against both Gram-positive and Gram-negative bacteria. |
| Institute of Oceanology Chinese Academy of Sciences | Antifungal applications in biomedical and agricultural fields requiring enhanced water solubility and broad-spectrum antimicrobial efficacy. | Quaternized Carboxymethyl Chitosan Derivatives | Enhanced antifungal activity combining benefits of quaternized chitosan and carboxymethyl chitosan, with improved water solubility and bioactivity through Schiff base intermediate synthesis. |
| Shandong University | Drug development and cancer therapy applications requiring improved peptide stability, targeted delivery, and enhanced therapeutic efficacy in tumor treatment. | Quaternized Chitosan Oligosaccharide-Modified ES-2 Peptide | Higher stability, longer half-life, enhanced cell affinity and stronger biological activity compared to unmodified ES-2 peptides, with anti-angiogenesis and anti-tumor properties. |